Gene · 114770
PGLYRP2: peptidoglycan recognition protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PGLYRP2: peptidoglycan recognition protein 2. Genes, record 114770. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/114770
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96PD5 | N-acetylmuramoyl-L-alanine amidase | 576 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents57
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 7019 | Q96PD5 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 10305 | Q96PD5 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2230 | Q96PD5 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3455 | Q96PD5 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7336 | Q96PD5 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3455 | Q96PD5 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7336 | Q96PD5 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7019 | Q96PD5 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 10305 | Q96PD5 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 10305 | Q96PD5 | Espacenet |
1 to 10 of 57
See all 57 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants725
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PGLYRP2 papers | Newest fiscal year |
|---|---|---|---|
| R01AI083365 | Envelope biogenesis in Escherichia coli and Pseudomonas aeruginosa | 7 | 2025 |
| P20GM103440 | Nevada IDeA Networks of Biomedical Research Excellence (INBRE) | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| R37AI033493 | Mechanisms of Gonococcal Pilin Antigenic and Phase Variation | 3 | 2025 |
| P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 2 | 2025 |
| P20GM103476 | Mississippi INBRE | 2 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 725Source NIH's project files
See all 725 nih grantsPapers1,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enrichment Performance Assessment of Extracellular Vesicles Using Different Functionalized Magnetic Materials and Application in Urinary Proteomics of Prostate Cancer. | ACS Appl Mater Interfaces | 2026 | 42686225 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures in Alkaptonuria. | Biology (Basel) | 2026 | 42589138 | PubTator, text mining | PubMed |
| Phages as antimicrobials against multi-drug resistant bacteria. | Front Microbiol | 2026 | 41809603 | PubTator, text mining | PubMed |
| Temporal lobe epilepsy is associated with neuroinflammation, extracellular matrix remodeling, and synaptic protein alterations. | Front Mol Neurosci | 2026 | 41800185 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| Cross-ancestry comparison of aptamer and antibody protein measures. | Nat Commun | 2026 | 41571639 | PubTator, text mining | PubMed |
| Plasma exosomal miR-122-5p_R-1, miR-23b-3p_R + 1, and miR-15a-5p_R-1 are associated with multidrug-resistant tuberculosis. | BMC Infect Dis | 2025 | 40855526 | PubTator, text mining | PubMed |
| Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk. | Alzheimers Dement | 2025 | 40810263 | PubTator, text mining | PubMed |
| Proteomics Used in Identifying Novel Correlates of Disease in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease. | Clin Transl Sci | 2025 | 40522163 | PubTator, text mining | PubMed |
| A DoE-guided development and validation of a novel HPLC method for determining N-acetylmuramoyl-L-alanine amidase activity via p-nitroaniline quantification. | Anal Methods | 2025 | 40309876 | PubTator, text mining | PubMed |
1 to 10 of 1,575
See all 1,575 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/114770
GET https://conductscience.org/api/genes/v1/114770/patents?page=2